Metformin in Psoriatic Arthritis

Summary

Psoriatic arthritis (PsA) is a systemic, inflammatory disease. The chronic inflammation in PsA predisposes patients to the metabolic syndrome (MetS). MetS is associated with systemic inflammation and proinflammatory cytokines. Clinical observations and experimental results argue for an anti-inflammatory and immunosuppressant property of MET.

Timeline

Start

2013-09

Primary completion

2014-03

Completion

2014-04

Drugs

Indications